AstraZeneca Completes $1B EsoBiotec Purchase
AstraZeneca PLC said Tuesday it has completed its acquisition of EsoBiotec SA, a Belgian biotechnology firm, for up to $1 billion as the pharmaceutical giant seeks to bolster its cancer treatment...To view the full article, register now.
Already a subscriber? Click here to view full article